BioDelivery Sciences International Stock Price and Value Analysis

Should you buy BioDelivery Sciences International stock? (NasdaqCM:BDSI). Let's see how it does in our automated value investing analysis system.

BDSI Free Cash Flow Trend

Free Cash Flow trendline for BDSI — Free Cash Flow trendline for BioDelivery Sciences International

Hmm, we can't give any reliable projection for BioDelivery Sciences International's growth rate. The company either has too few years of historical data for us to examine, or it's in the habit of losing money.

None of this means it's a bad stock. Maybe it's new and growing quickly, or maybe it's turning things around. We can't say anything sensible about it, so we won't say it's obviously undervalued right now. Proceed at your own risk!

Advantages	Disadvantages	Neutral
None.	This stock looks overpriced. This company is less known than others. This company is not making money. This company has wild ups and downs.	This company pays no dividend.

Inside the BDSI Numbers

	BDSI Price (BioDelivery Sciences International stock price per share)	$4.35
	PE Ratio versus Sector	59% higher than other Healthcare stocks
	PE Ratio versus Industry	44% lower than other Biotechnology stocks
	Cash Yield	-0.96%
	Free Cash Flow Jitter	63%

Is BioDelivery Sciences International Stock on Sale?

Based on our analysis, we believe that you should not buy BioDelivery Sciences International right now. It might be a good stock to own—we just can't prove it with value analysis right now. Proceed with caution.

Should You Buy BDSI Stock?

Does BioDelivery Sciences International have a coherent story? Does it have a plan to continue to make money? Is it worth your time? Only you can decide where to go from here. Our investment guide helps you ask the right questions, including how to buy stocks. Use these research links for more information.